Ellis Chu
Director of Finance/CFO bij JHL BIOTECH, INC.
Profiel
Momenteel bekleedt Ellis Chu de functie van Chief Financial Officer bij JHL Biotech, Inc. en Chief Financial Officer & Senior Vice President bij WuXi AppTec Co., Ltd. In zijn vorige loopbaan was hij Managing Director bij Ion Pacific Ltd., Managing Director bij Merrill Lynch (Asia Pacific) Ltd., Director-Asia IBD bij Citigroup Global Markets Asia Ltd. en Vice President-Investment Banking bij Nomura International (Hong Kong) Ltd. De heer Chu behaalde een doctoraal aan de Northwestern University en een MBA aan de Columbia Business School.
Actieve functies van Ellis Chu
Bedrijven | Functie | Begin |
---|---|---|
JHL BIOTECH, INC. | Director of Finance/CFO | 01-05-2018 |
WUXI APPTEC CO., LTD. | Director of Finance/CFO | - |
Eerdere bekende functies van Ellis Chu
Bedrijven | Functie | Einde |
---|---|---|
Ion Pacific Ltd.
Ion Pacific Ltd. Investment ManagersFinance Ion Pacific Ltd (Ion Pacific) is a private equity/venture capital firm founded in 2015 by Itamar Har-Even and Michael Joseph. The firm is headquartered in New York. | Corporate Officer/Principal | - |
Citigroup Global Markets Asia Ltd.
Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Corporate Officer/Principal | - |
Merrill Lynch (Asia Pacific) Ltd.
Merrill Lynch (Asia Pacific) Ltd. Investment ManagersFinance Merrill Lynch (Asia Pacific) Ltd. (Merrill Lynch-Asia Pacific) is the financial management subsidiary of Merrill Lynch HK Services, Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. Based in Hong Kong, the firm provides financial management and advisory services. | Corporate Officer/Principal | - |
Nomura International (Hong Kong) Ltd.
Nomura International (Hong Kong) Ltd. Investment Banks/BrokersFinance Nomura International (Hong Kong) Ltd. (Nomura International HK) is the brokerage subsidiary of Nomura Asia Pacific Holdings Co. Ltd., which is ultimately-owned by Nomura Holdings, Inc. (TYO: 8604) in Japan. Headquartered in Hong Kong, the firm’s global markets team offers research, sales and trading of global securities to a diverse range of clients globally, including institutional investors, financial institutions, corporates, financial sponsors and government entities. Nomura International HK operates a truly integrated, cross-asset platform which includes research, sales and trading in equities, currencies, rates and credit in cash and derivative products. | Corporate Officer/Principal | - |
Opleiding van Ellis Chu
Northwestern University | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
WUXI APPTEC CO., LTD. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Nomura International (Hong Kong) Ltd.
Nomura International (Hong Kong) Ltd. Investment Banks/BrokersFinance Nomura International (Hong Kong) Ltd. (Nomura International HK) is the brokerage subsidiary of Nomura Asia Pacific Holdings Co. Ltd., which is ultimately-owned by Nomura Holdings, Inc. (TYO: 8604) in Japan. Headquartered in Hong Kong, the firm’s global markets team offers research, sales and trading of global securities to a diverse range of clients globally, including institutional investors, financial institutions, corporates, financial sponsors and government entities. Nomura International HK operates a truly integrated, cross-asset platform which includes research, sales and trading in equities, currencies, rates and credit in cash and derivative products. | Finance |
Merrill Lynch (Asia Pacific) Ltd.
Merrill Lynch (Asia Pacific) Ltd. Investment ManagersFinance Merrill Lynch (Asia Pacific) Ltd. (Merrill Lynch-Asia Pacific) is the financial management subsidiary of Merrill Lynch HK Services, Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. Based in Hong Kong, the firm provides financial management and advisory services. | Finance |
Citigroup Global Markets Asia Ltd.
Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Finance |
Eden Biologics, Inc.
Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
Ion Pacific Ltd.
Ion Pacific Ltd. Investment ManagersFinance Ion Pacific Ltd (Ion Pacific) is a private equity/venture capital firm founded in 2015 by Itamar Har-Even and Michael Joseph. The firm is headquartered in New York. | Finance |